Glycan Sequencing Market

Glycan Sequencing Market: Global Industry Analysis 2014 -2018 and Opportunity Assessment; 2019 - 2029 Overview

Minor glycan sequencing is carried out in order to determine the characteristics and functionalities of glycan present in glycoconjugates. The wide variety of glycosylation causes hindrance in the elucidation procedure and hence requires the addition of other orthogonal methods to ensure clarity in the glycan profile.

The techniques involved in glycan sequencing are high performance liquid chromatography, Mass spectrometry, and electrophoresis. These methods involve digestion through enzymes such as exoglycosidase. Any changes in glycan structure and their identification can be responsible for diseases.

Glycans and glycan binding protein are linked to some disease diagnosis. They aren’t the primary precursors of disease but can add clarity to diagnosis reports. Some pathogens present in GI tract recognize glycans and can be a factor in dealing with this genre of diseases. Glycan sequencing can provide aid in studying these aspects. Epithelial ovarian cancer ranks fifth in the cancers related to women.

The glycans present in the membrane are exposed to alteration during carcinogenesis and hence cancer is the field of scope for glycan sequencing market.

Glycan Sequencing Market: Drivers and Restraints

The growing prevalence in glycobiology carrying out studies of different carbohydrate and protein is a driver of glycan sequencing market. The introduction of new researches in the field of proteomics in North America, Europe, East Asian regions is a major driver of glycan sequencing market. The analysis of non- inheritable diseases in protein level is prevalent in a considerable number of regions and is a major driver for glycan sequencing market.

The increasing expenditures in healthcare is a driver for glycan sequencing market. The increasing awareness of cancer research especially ovarian cancer is a driver for glycan sequencing market. The importance of glycan sequencing in biopharmaceuticals due to the attraction of pathogen towards unusual glycan sequences is a potential driver for this market.

Biopharmaceuticals is a growing field and have potential for growth of glycan sequence market. The glycobiology of glycans are partially linked with development immunology and can be a driver for the glycan sequencing market. Proteoglycans have functional importance in neurobiology and can have a scope for glycan sequencing market.

Glycan Sequencing Market: Overview

The glycan sequencing technologies are of key importance in metabolomics. Glycan sequencing market has key importance in studying the structural and physical frame of various biological processes. Enzymatic procedures are the most common methods for glycan sequencing. They are more feasible methods for glycan sequencing.

Some unusual sequences of glycan are more prone to toxins and pathogens and hence there is scope for glycan sequencing market in biopharmaceuticals. There is a wide range of disorders resulting due to glycosylation and hence the role of glycan sequencing in diagnostic centers. They are involved in the identification of some cancer biomarkers.

The glycans which are present in membranes are vulnerable to carcinogenesis in some cases. These aspects are driving the market for glycan sequencing.

Glycan Sequencing Market: Regional Overview

North America is expected to be the dominant market in glycobiology research. Europe also contributes considerably to the field of proteomics. These two regions can be a key region for glycan sequencing market to grow.

The United Kingdom has a significant number of research centres involved in metabolomics and can be a dominant area for glycan sequencing market. There are some metabolomics research centers originating in China.

Japan also has a significant number of research labs in metabolomics. East Asia can be a profitable market for glycan sequencing market.

Glycan Sequencing Market: Key Players

Some of the Key players in the glycan sequencing market include

• Merck & Co Inc
• Charles River
• SCIEX
• New England Biolabs
• Lake Pharma Inc
• Biocompare and Promega Corporation

The research report on glycan sequencing market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.

The research report on glycan sequencing market provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on glycan sequencing market

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Report includes regional analysis

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Europe (Germany, Italy, France, U.K, Spain, , Russia)
• East Asia (China, Japan, South Korea)
• South Asia (India, ASEAN)
• Oceania (Australia, New Zealand)
• Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report on Glycan Sequencing market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Glycan Sequencing Market: Segmentation

The global glycan sequencing market is classified on the basis of types of sequencing, application and end user and geographic region.

Based on Types of sequencing, the glycan sequencing market is segmented into:

• By using enzyme Endoglycoceramidase
• Hydrazinolysis
• Alkaline Borohydride Treatment
• By using enzyme Endoglycosidase
• By using Exoglycosidase

Based on application, the glycan sequencing market is segmented into:

• Glycobiology
• Proteomics
• Neurobiology
• Developmental Immunology
• Biotherapeutics
• Antibody production

Based on end user, the glycan sequencing market is segmented into:

• Research centers
• Academic Institutes
• Diagnostic Centers
• Cancer Research Labs